Your browser doesn't support javascript.
loading
Delineating the role of cooperativity in the design of potent PROTACs for BTK.
Zorba, Adelajda; Nguyen, Chuong; Xu, Yingrong; Starr, Jeremy; Borzilleri, Kris; Smith, James; Zhu, Hongyao; Farley, Kathleen A; Ding, WeiDong; Schiemer, James; Feng, Xidong; Chang, Jeanne S; Uccello, Daniel P; Young, Jennifer A; Garcia-Irrizary, Carmen N; Czabaniuk, Lara; Schuff, Brandon; Oliver, Robert; Montgomery, Justin; Hayward, Matthew M; Coe, Jotham; Chen, Jinshan; Niosi, Mark; Luthra, Suman; Shah, Jaymin C; El-Kattan, Ayman; Qiu, Xiayang; West, Graham M; Noe, Mark C; Shanmugasundaram, Veerabahu; Gilbert, Adam M; Brown, Matthew F; Calabrese, Matthew F.
Afiliação
  • Zorba A; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, MA 02139.
  • Nguyen C; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Xu Y; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Starr J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Borzilleri K; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Smith J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Zhu H; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Farley KA; Computational Sciences, Medicinal Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Ding W; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Schiemer J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Feng X; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Chang JS; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Uccello DP; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Young JA; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Garcia-Irrizary CN; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Czabaniuk L; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Schuff B; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Oliver R; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Montgomery J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Hayward MM; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Coe J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Chen J; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Niosi M; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Luthra S; Medicine Design, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Shah JC; Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Cambridge, MA 02139.
  • El-Kattan A; Pharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Cambridge, MA 02139.
  • Qiu X; Medicine Design, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • West GM; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Noe MC; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Shanmugasundaram V; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Gilbert AM; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Brown MF; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
  • Calabrese MF; Discovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340.
Proc Natl Acad Sci U S A ; 115(31): E7285-E7292, 2018 07 31.
Article em En | MEDLINE | ID: mdl-30012605
Proteolysis targeting chimeras (PROTACs) are heterobifunctional small molecules that simultaneously bind to a target protein and an E3 ligase, thereby leading to ubiquitination and subsequent degradation of the target. They present an exciting opportunity to modulate proteins in a manner independent of enzymatic or signaling activity. As such, they have recently emerged as an attractive mechanism to explore previously "undruggable" targets. Despite this interest, fundamental questions remain regarding the parameters most critical for achieving potency and selectivity. Here we employ a series of biochemical and cellular techniques to investigate requirements for efficient knockdown of Bruton's tyrosine kinase (BTK), a nonreceptor tyrosine kinase essential for B cell maturation. Members of an 11-compound PROTAC library were investigated for their ability to form binary and ternary complexes with BTK and cereblon (CRBN, an E3 ligase component). Results were extended to measure effects on BTK-CRBN cooperative interactions as well as in vitro and in vivo BTK degradation. Our data show that alleviation of steric clashes between BTK and CRBN by modulating PROTAC linker length within this chemical series allows potent BTK degradation in the absence of thermodynamic cooperativity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Ubiquitina-Proteína Ligases / Ubiquitinação / Proteólise Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Ubiquitina-Proteína Ligases / Ubiquitinação / Proteólise Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2018 Tipo de documento: Article